What is Monte Rosa Therapeutics, Inc.'s change in AP?

Monte Rosa Therapeutics, Inc. (GLUE) reported change in AP of $4.38M in Q1 2026.

How has Monte Rosa Therapeutics, Inc.'s change in AP changed year-over-year?

Monte Rosa Therapeutics, Inc.'s change in AP increased by 140.3% year-over-year, from -$10.87M to $4.38M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Monte Rosa Therapeutics, Inc. GLUE Change in AP

Change in AP at other companies

Bristol-Myers SquibbBMY

$409M+581%

Nurix Therapeutics, Inc.NRIX

-$461K+85.6%

Kymera TherapeuticsKYMR

$8.82M+125%

ImmunomeIMNM

$1.42M+137%

Cogent Biosciences, Inc.COGT

$4.24M+98.0%

Adaptive BiotechnologiesADPT

-$7.51M+22.3%

Other financials

Income statement

See full

Revenue$4.2M-95.0%

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.75B+361%

Enterprise value$1.63B+381%

P/S40.7×+38.4×

Profitability

See full

Operating margin-345.2%—

Net margin-302.6%—

FCF margin-45.8%-64.9pp

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Reported directly by Monte Rosa Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s change in AP?: Monte Rosa Therapeutics, Inc. (GLUE) reported change in AP of $4.38M in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s change in AP changed year-over-year?: Monte Rosa Therapeutics, Inc.'s change in AP increased by 140.3% year-over-year, from -$10.87M to $4.38M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.